| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.05. | NEXSEN LIMITED: Becoming a substantial holder | - | ASX | ||
| 13.05. | Nexsen Secures First Asian Hospital Partner for Diagnostic Commercialisation | 2 | smallcaps.com.au | ||
| 12.05. | NEXSEN LIMITED: Nexsen secures first hospital partner in Asia | - | ASX | ||
| 03.05. | NEXSEN LIMITED: Nexsen and Universiti Malaya launch joint facility | - | ASX | ||
| 28.04. | NEXSEN LIMITED: Quarterly Report - Q3 FY26 | - | ASX | ||
| 06.04. | NEXSEN LIMITED: QMS milestone achieved | - | ASX | ||
| 31.03. | Nexsen Awarded $1.2m Grant to Advance Strepsure Point-Of-Care Diagnostic in Asia-Pacific Markets | 1 | smallcaps.com.au | ||
| NEXSEN Aktie jetzt für 0€ handeln | |||||
| 30.03. | NEXSEN LIMITED: HK$6 million grant awarded to advance Asia-Pacific execution | - | ASX | ||
| 26.03. | Nexsen accelerates global rollout for StrepSure | 1 | The Market Herald Australia | ||
| 25.03. | NEXSEN LIMITED: Nexsen accelerates global rollout for StrepSure | - | ASX | ||
| 22.03. | NEXSEN LIMITED: FDA feedback derisks US approval pathway for StrepSure | - | ASX | ||
| 26.02. | NEXSEN LIMITED: Half Yearly Report and Accounts | - | ASX | ||
| 26.02. | NEXSEN LIMITED: Change in substantial holding - Nexsen | - | ASX | ||
| 24.02. | NEXSEN LIMITED: Nexsen highlights GBS strategy at ISSAD 2026 | - | ASX | ||
| 24.02. | NEXSEN LIMITED: Application for quotation of securities - NXN | - | ASX | ||
| 05.02. | NEXSEN LIMITED: Change in substantial holding - Nexsen | - | ASX | ||
| 05.02. | NEXSEN LIMITED: Application for quotation of securities - NXN | - | ASX | ||
| 29.01. | NEXSEN LIMITED: Quarterly Report - Q2 FY26 | - | ASX | ||
| 26.01. | NEXSEN LIMITED: $500k govt grant expands GBS project to neonates | - | ASX | ||
| 23.01. | NEXSEN LIMITED: Notice under ASX Listing Rule 3.10A | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 20,050 | +1,98 % | Formycon bringt Aflibercept-Biosimilar in der EU auf den Markt | Die Formycon AG hat ihr Aflibercept-Biosimilar FYB203 ab dem 15. Mai 2026 in der Europäischen Union unter den Markennamen Ahzantive und Baiama als Fertigspritze eingeführt. Die Markteinführung startete... ► Artikel lesen | |
| RIBER | 15,280 | +0,39 % | Riber: Margen steigen, KI-Boom treibt - Hidden Champion vor nächsten Kursschub? | Hightech "Made in France" mit Rückenwind durch KI und Photoniks: Riber verbessert trotz leicht rückläufigem Umsatz deutlich seine Profitabilität und könnte vor einem neuen Wachstumszyklus stehen. Riber... ► Artikel lesen | |
| ONTO INNOVATION | 224,50 | -0,71 % | Onto Innovation prices $1.3B convertible senior notes offering due 2031 | ||
| SMOLTEK NANOTECH | 0,217 | -3,12 % | Communiqué from the 2026 Annual General Meeting of Smoltek Nanotech Holding AB (publ) | ||
| KOPIN | 4,440 | -0,04 % | Fabric.AI (Nasdaq: FABC) and Kopin Corporation (Nasdaq: KOPN) Appoint Bill Maffucci to Lead Development of Neural I/o MicroLED Optical Interconnect Chip Program | NEW YORK, NY, May 06, 2026 (GLOBE NEWSWIRE) -- Fabric.AI (Nasdaq: FABC) ("Fabric.AI" or "the Company"), an AI infrastructure company developing a suite of fabless semiconductor technologies for next-generation... ► Artikel lesen | |
| GOMSPACE | 1,964 | -1,46 % | GomSpace A/S: GomSpace reports a solid Q1 with 43% revenue growth and positive EBITDA | GomSpace continues to demonstrate strong revenue growth, delivers positive EBITDA, and takes first step toward delivering sovereign satellite communication solutions in Ukraine.STOCKHOLM... ► Artikel lesen | |
| OBDUCAT | 0,036 | +2,86 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| GAUZY | 0,674 | +2,08 % | GAUZY LTD: Gauzy Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | TEL AVIV, Israel, March 20, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on March 17... ► Artikel lesen | |
| SOLESENCE | 1,240 | -0,40 % | Solésence, Inc.: Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Alle Awards, Marking Fourth Year of Recognition | ||
| VEECO INSTRUMENTS | 50,62 | -1,33 % | Veeco Instruments Inc.: Veeco Announces Upcoming Investor Events | ||
| NANOFORM FINLAND | 0,878 | +9,61 % | Nanoform Finland Oyj: Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology | Nanoform Finland Plc | Company Release | May 19, 2026 at 08:10:00 EEST
Record first quarter revenue, income and gross margin. Revenue grew by 45%, gross margin reached 94% and operating costs fell by... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,180 | +19,21 % | FendX Technologies Inc.: FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program | Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection... ► Artikel lesen | |
| ACACIA RESEARCH | 3,940 | 0,00 % | Acacia Research Q1 2026 slides show mixed results, strong liquidity | ||
| NVE | 78,50 | 0,00 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,414 | -0,48 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky |